The Journal of Immunology, Vol 146, Issue 1 81-84, Copyright © 1991 by American Association of Immunologists

ARTICLES

Cocaine potentiates HIV-1 replication in human peripheral blood mononuclear cell cocultures. Involvement of transforming growth factor- beta

PK Peterson, G Gekker, CC Chao, R Schut, TW Molitor and HH Balfour Jr
Department of Medicine, Hennepin County Medical Center, Minneapolis, MN 55415.

Cocaine use is an important high risk behavior in the AIDS epidemic. In this study, we tested the hypothesis that cocaine potentiates the replication of HIV-1 in human PBMC. A coculture system was used in which PBMC from healthy donors were incubated in the absence (control) or presence of cocaine before activation with PHA. Cocultures were then constituted with PBMC infected with a clinical isolate of HIV-1. HIV-1 replication, which was assessed by the measurement of HIV-1 p24 antigen levels in coculture supernatants, was significantly increased in a dose- dependent manner by cocaine with maximal stimulation at a concentration of 10(-9) M (965 +/- 196 vs 303 +/- 80 pg p24 Ag/ml in control cocultures). Antibodies to transforming growth factor-beta (TGF-beta) blocked cocaine-enhanced HIV-1 replication and purified TGF-beta stimulated viral replication in a manner similar to that observed with cocaine. Augmentation of HIV-1 replication by TGF-beta was maximal at a concentration of 0.01 ng/ml; however, viral proliferation appeared to be inhibited by concentrations of TGF-beta of 1 ng/ml or greater. Taken together, these results indicate that cocaine augments the replication of HIV-1 in PHA-activated PBMC via a mechanism that appears to involve TGF-beta.

This article has been cited by other articles:

				C. Gore-Felton and C. Koopman Behavioral Mediation of the Relationship Between Psychosocial Factors and HIV Disease Progression Psychosom Med, June 1, 2008; 70(5): 569 - 574. [Abstract] [Full Text] [PDF]

				M. D. Roth, K. M. Whittaker, R. Choi, D. P. Tashkin, and G. C. Baldwin Cocaine and {sigma}-1 receptors modulate HIV infection, chemokine receptors, and the HPA axis in the huPBL-SCID model J. Leukoc. Biol., December 1, 2005; 78(6): 1198 - 1203. [Abstract] [Full Text] [PDF]

				M. Moriuchi and H. Moriuchi Cell-Type-Dependent Effect of Transforming Growth Factor {beta}, a Major Cytokine in Breast Milk, on Human Immunodeficiency Virus Type 1 Infection of Mammary Epithelial MCF-7 Cells or Macrophages J. Virol., December 1, 2004; 78(23): 13046 - 13052. [Abstract] [Full Text] [PDF]

				H. Friedman, C. Newton, and T. W. Klein Microbial Infections, Immunomodulation, and Drugs of Abuse Clin. Microbiol. Rev., April 1, 2003; 16(2): 209 - 219. [Abstract] [Full Text] [PDF]

				C. Casoli, E. Vicenzi, A. Cimarelli, G. Magnani, P. Ciancianaini, E. Cattaneo, P. Dall'Aglio, G. Poli, and U. Bertazzoni HTLV-II down-regulates HIV-1 replication in IL-2-stimulated primary PBMC of coinfected individuals through expression of MIP-1alpha Blood, May 1, 2000; 95(9): 2760 - 2769. [Abstract] [Full Text] [PDF]

				K. Grattendick, D. B. Jansen, D. L. Lefkowitz, and S. S. Lefkowitz Cocaine Causes Increased Type I Interferon Secretion by both L929 Cells and Murine Macrophages Clin. Vaccine Immunol., March 1, 2000; 7(2): 245 - 250. [Abstract] [Full Text] [PDF]

				G. C. BALDWIN, D. P. TASHKIN, D. M. BUCKLEY, A. N. PARK, S. M. DUBINETT, and M. D. ROTH Marijuana and Cocaine Impair Alveolar Macrophage Function and Cytokine Production Am. J. Respir. Crit. Care Med., November 1, 1997; 156(5): 1606 - 1613. [Abstract] [Full Text]

				S. H. Landesman, L. A. Kalish, D. N. Burns, H. Minkoff, H. E. Fox, C. Zorrilla, P. Garcia, M. G. Fowler, L. Mofenson, R. Tuomala, et al. Obstetrical Factors and the Transmission of Human Immunodeficiency Virus Type 1 from Mother to Child N. Engl. J. Med., June 20, 1996; 334(25): 1617 - 1623. [Abstract] [Full Text] [PDF]

				A. Fauci Multifactorial nature of human immunodeficiency virus disease: implications for therapy Science, November 12, 1993; 262(5136): 1011 - 1018. [Abstract] [PDF]